share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K：诺和诺德-股票回购计划
美股SEC公告 ·  07/29 07:52

Moomoo AI 已提取核心信息

Novo Nordisk A/S, a leading global healthcare company, has been actively executing its share repurchase program, which was announced on May 6, 2024. As part of a larger 12-month share repurchase initiative with a budget of up to DKK 20 billion that started on February 6, 2024, the company has been buying back B shares. From May 7, 2024, to August 5, 2024, Novo Nordisk is set to repurchase B shares worth up to DKK 2.2 billion. The latest transactions, reported on July 29, 2024, show that since the last announcement on July 22, 2024, the company has acquired an additional 201,500 B shares, spending approximately DKK 181,490,215. This brings the total repurchased under the program to 2,086,287 B shares at a cost of DKK 1,980,536,332. Novo Nordisk now holds 12,186,327 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has been actively executing its share repurchase program, which was announced on May 6, 2024. As part of a larger 12-month share repurchase initiative with a budget of up to DKK 20 billion that started on February 6, 2024, the company has been buying back B shares. From May 7, 2024, to August 5, 2024, Novo Nordisk is set to repurchase B shares worth up to DKK 2.2 billion. The latest transactions, reported on July 29, 2024, show that since the last announcement on July 22, 2024, the company has acquired an additional 201,500 B shares, spending approximately DKK 181,490,215. This brings the total repurchased under the program to 2,086,287 B shares at a cost of DKK 1,980,536,332. Novo Nordisk now holds 12,186,327 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and the New York Stock Exchange.
领先全球医疗保健公司丹波诺丝克自2024年5月6日宣布股票回购计划以来，一直在积极执行此项计划。作为一个12个月总预算达200亿丹麦克朗的更大规模的股票回购倡议的一部分，自2024年2月6日开始，该公司一直在回购B股。自2024年5月7日至8月5日，丹波诺丝克将回购价值达22亿丹麦克朗的B股。最新交易情况于2024年7月29日公布，显示自7月22日上次公告以来，该公司已额外收购2015000亿股，总计花费约181,490,215丹麦克朗。该计划下总共回购了20862870亿股，花费了1,980,536,332丹麦克朗。丹波诺丝克现持有121863270亿股库藏股，占股本的0.3%。该公司股票在纳斯达克哥本哈根交易所和纽约证交所上市。
领先全球医疗保健公司丹波诺丝克自2024年5月6日宣布股票回购计划以来，一直在积极执行此项计划。作为一个12个月总预算达200亿丹麦克朗的更大规模的股票回购倡议的一部分，自2024年2月6日开始，该公司一直在回购B股。自2024年5月7日至8月5日，丹波诺丝克将回购价值达22亿丹麦克朗的B股。最新交易情况于2024年7月29日公布，显示自7月22日上次公告以来，该公司已额外收购2015000亿股，总计花费约181,490,215丹麦克朗。该计划下总共回购了20862870亿股，花费了1,980,536,332丹麦克朗。丹波诺丝克现持有121863270亿股库藏股，占股本的0.3%。该公司股票在纳斯达克哥本哈根交易所和纽约证交所上市。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间